Published in BMJ on March 28, 1998
How should cost data in pragmatic randomised trials be analysed? BMJ (2000) 6.66
Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ (1998) 3.71
[Value of inpatient care in rheumatoid arthritis-an evidence based report]. Z Rheumatol (2004) 1.39
Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Ann Rheum Dis (2003) 1.23
Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis. Ann Rheum Dis (2000) 0.96
A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multi-centre study. Int J Nurs Stud (2011) 0.86
Successfully living with chronic arthritis. The role of the allied health professionals. Clin Rheumatol (2005) 0.78
Illness perceptions in patients receiving rheumatology rehabilitation: association with health and outcomes at 12 months. BMC Musculoskelet Disord (2013) 0.77
Cost of illness for patients with arthritis receiving multidisciplinary rehabilitation care. Rehabil Res Pract (2011) 0.76
Involvement of the multidisciplinary team and outcomes in inpatient rehabilitation among patients with inflammatory rheumatic disease. BMC Musculoskelet Disord (2016) 0.75
Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials. Rheumatology (Oxford) (2016) 0.75
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
A new design for randomized clinical trials. N Engl J Med (1979) 7.85
A utility maximization model for evaluation of health care programs. Health Serv Res (1972) 6.67
Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol (1986) 5.82
Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc (1949) 4.18
Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med (1996) 3.25
On the decision rules of cost-effectiveness analysis. J Health Econ (1993) 2.09
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med (1986) 2.08
Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum (1996) 1.56
Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum (1989) 1.55
Costs and cost-minimisation analysis. BMJ (1993) 1.52
Economic analysis in randomized control trials. Med Care (1992) 1.52
Equivalence trials. N Engl J Med (1997) 1.48
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Screening and surveillance of pregnancy hypertension--an economic approach to the use of daycare. Baillieres Clin Obstet Gynaecol (1990) 1.10
Day hospital as an alternative to inpatient care for cancer patients: a random assignment trial. J Clin Epidemiol (1988) 1.07
The two-year follow-up of a randomized comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis. Br J Rheumatol (1997) 0.94
Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis. J Rheumatol (1988) 0.87
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Cost and effectiveness of a Geriatric Day Hospital. J R Coll Physicians Lond (1982) 0.84
Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond (1992) 0.80
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
The possible significance of hexosephosphoric esters in ossification: Calcification in vitro. Biochem J (1930) 6.09
Quality and the use of time in general practice: widening the discussion. BMJ (1989) 5.59
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 2.89
Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty. Treatment of displaced intracapsular hip fractures in healthy older patients. J Bone Joint Surg Am (2006) 2.71
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol (1992) 2.67
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis (1973) 2.12
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis (1967) 1.89
Integrated dialysis and renal transplantation: small is beautiful. Br Med J (1980) 1.85
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol (2003) 1.75
Trends in childhood injury mortality in Canada, 1979-2002. Inj Prev (2006) 1.73
Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg (2007) 1.70
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Polymyalgia rheumatica. Practitioner (1973) 1.58
Practice budgets: lifting the veil of ignorance. J R Coll Gen Pract (1989) 1.56
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Balanitis xerotica obliterans in children. Pediatr Pathol (1987) 1.51
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) (1986) 1.49
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Ann Oncol (2011) 1.49
Does waiting matter? A randomized controlled trial of new non-urgent rheumatology out-patient referrals. Rheumatology (Oxford) (2000) 1.48
Maternal and neonatal morbidity in relation to the instrument used for mid-cavity rotational operative vaginal delivery: a prospective cohort study. BJOG (2013) 1.45
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group. Ann Oncol (1996) 1.41
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Ann Rheum Dis (1969) 1.39
Rheumatoid lymphadenopathy. Ann Rheum Dis (1968) 1.39
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
Non-steroidal analgesic and anti-inflammatory agents. Br Med J (Clin Res Ed) (1983) 1.35
Displaced intracapsular hip fractures in fit, older people: a randomised comparison of reduction and fixation, bipolar hemiarthroplasty and total hip arthroplasty. Health Technol Assess (2005) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.28
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Ann Oncol (2009) 1.26
Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25
Stimulation of human purine synthesis de novo by fructose infusion. Metabolism (1975) 1.25
Dermatitis herpetiformis--a skin manifestation of a generalized disturbance in immunity. Q J Med (1978) 1.24
Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction? Lancet (1980) 1.21
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. Lancet (1996) 1.21
Signalling cascades in mechanotransduction: cell-matrix interactions and mechanical loading. Scand J Med Sci Sports (2009) 1.20
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum (2000) 1.19
Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ (2000) 1.19
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer (2010) 1.18
Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect (2008) 1.15
Radioisotope study of small joint inflammation in rheumatoid arthritis. Ann Rheum Dis (1971) 1.15
Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. Br J Rheumatol (1986) 1.14
A randomised controlled trial of routine versus restrictive use of episiotomy at operative vaginal delivery: a multicentre pilot study. BJOG (2008) 1.14
Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol (1972) 1.13
Integrin and mechanosensitive ion channel-dependent tyrosine phosphorylation of focal adhesion proteins and beta-catenin in human articular chondrocytes after mechanical stimulation. J Bone Miner Res (2000) 1.13
Leucocyte antigens in Hodgkin's disease. Lancet (1970) 1.13
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique. Clin Sci (1971) 1.10
Rheological simulation of synovial fluid by a synthetic polymer solution. Nature (1969) 1.09
Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technol Assess (2010) 1.08
Integrin-interleukin-4 mechanotransduction pathways in human chondrocytes. Clin Orthop Relat Res (2001) 1.08
Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes. J Cell Biol (1999) 1.07
Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol (1970) 1.07
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Eating and corticosteroid levels. Br Med J (1969) 1.06
Hyperpolarisation of cultured human chondrocytes following cyclical pressure-induced strain: evidence of a role for alpha 5 beta 1 integrin as a chondrocyte mechanoreceptor. J Orthop Res (1997) 1.05
EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene (1998) 1.05
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer. Ann Oncol (2009) 1.04
Bone mass in ankylosing spondylitis. J Rheumatol (1986) 1.02
Macrovascular disease and systemic sclerosis. Ann Rheum Dis (2000) 1.02
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int (2004) 1.00
Resource use and costs of elective surgery for asymptomatic abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (1997) 1.00
Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann Rheum Dis (1970) 0.99
Concurrent colonic adenocarcinoma and two ileal carcinoids in a 72-year-old male. Aust N Z J Surg (1997) 0.99
Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 0.99
The economics of arthritis. Bull Rheum Dis (1973) 0.98
Health and behavioural change: some lay perspectives. Community Med (1987) 0.98
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
Bone mass in nodal primary generalised osteoarthrosis. Ann Rheum Dis (1984) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Ann Rheum Dis (1973) 0.96
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
A study of amyloid arthropathy in multiple myeloma. Q J Med (1981) 0.96